Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 21;10.1111/dom.14062.
doi: 10.1111/dom.14062. Online ahead of print.

Therapeutic Uncertainties in People With Cardiometabolic Diseases and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19)

Affiliations
Free PMC article

Therapeutic Uncertainties in People With Cardiometabolic Diseases and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19)

Sachin Khunti et al. Diabetes Obes Metab. .
Free PMC article

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) has been declared a pandemic by the World Health Organization and sent all countries scrambling to review emergency healthcare provisions. There is global evidence of each nation struggling to effectively manage the number of people being diagnosed with the virus. These are testing times which have not been experienced in recent generations and there are a number of insecurities regarding the management of people with COVID-19 and cardiometabolic diseases. This review highlights the current concerns related to COVID-19 and provides advice in terms of the therapeutic uncertainty and potential adverse harms associated with therapy when managing people, particularly those with cardiometabolic diseases, who have contracted or are at increased risk of contracting COVID-19.

Keywords: type 2 diabetes.

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Rodriguez‐Morales A, Cardona‐Ospina J, Gutiérrez‐Ocampo E, et al. Clinical, laboratory and imaging features of COVID‐19: a systematic review and meta‐analysis. Travel Med Infect Dis. 2020;101623 10.1016/j.tmaid.2020.101623. - DOI - PMC - PubMed
    1. Teljeur C, Smith SM, Paul G, Kelly A, O'Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013;19:17‐22. 10.3109/13814788.2012.714768. - DOI - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China. JAMA. 2020;323:1239 10.1001/jama.2020.2648. - DOI
    1. Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020. 10.1111/all.14238. - DOI
    1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID‐19 infection? Lancet Respir Med. 2020;8:e21 10.1016/s2213-2600(20)30116-8. - DOI - PMC - PubMed

LinkOut - more resources

Feedback